Bipolar disorder, current episode depressed, severe, without psychotic features
ICD-10 F31.4 is a billable code used to indicate a diagnosis of bipolar disorder, current episode depressed, severe, without psychotic features.
Bipolar disorder, classified under mood disorders, is characterized by alternating episodes of mania and depression. The current episode of F31.4 indicates a severe depressive episode without psychotic features. Patients may experience significant impairment in daily functioning, including difficulties in work, social interactions, and self-care. Symptoms may include persistent sadness, loss of interest in activities, fatigue, feelings of worthlessness, and suicidal ideation. The absence of psychotic features differentiates this episode from more severe forms of bipolar disorder, where hallucinations or delusions may be present. Treatment typically involves mood stabilizers, antidepressants, and psychotherapy. Regular monitoring for suicide risk is crucial, as individuals with severe depression are at heightened risk for self-harm. Accurate diagnosis and coding are essential for appropriate treatment and reimbursement.
Comprehensive mental status examination, treatment history, and risk assessments.
Initial evaluation of a patient presenting with depressive symptoms, follow-up visits for medication management.
Ensure clear documentation of mood episodes and any changes in treatment plans.
Detailed patient history, screening for depression, and referral notes to mental health specialists.
Routine check-ups where mood symptoms are discussed, management of comorbid conditions.
Collaboration with mental health providers for comprehensive care.
Used during therapy sessions for patients diagnosed with F31.4.
Document the duration of the session and the focus of therapy.
Psychiatrists should ensure that the therapy aligns with the treatment plan for bipolar disorder.
F31.4 specifically indicates a current severe depressive episode without psychotic features, which is crucial for treatment planning and risk assessment.